 |
 |
 |
 |
|
|
|
 |
|
|
|
Dr. Ken Alibek |
|
|
Executive Director for Education for George Mason University's National Center for Biodefense.
Distinguished Professor, Department of Molecular and Microbiology and President and Chief Scientist, Advanced Biosystems |
| |
Email: vettenge@gmu.edu |
| |
Website: http://www.gmu.edu/centers/biodefense/faculty_alibek.html |
|
|
Work Phone: (703) 993-8545 |
| |
Fax: |
| |
Office: |
| |
BioSketch:
Dr. Alibek served as First Deputy Chief of the civilian branch of the Soviet Union’s offensive biological weapons program and has more than twenty years of experience in the development, management and supervision of high containment (BL-4) pathogen laboratories. He has extensive knowledge of biotechnology, including, bioprocessing, biological weapons threat analysis; antibacterial and antiviral drug development; development of regimens for urgent prophylaxis and treatment of the diseases caused by biological weapons; and mass casualty handling. He is a former Soviet Army Colonel. Dr. Alibek has published articles in a number of classified journals on the development in the field of biological weapons, biological weapons threat, and on medical aspects of biodefense. He holds many patents, both Russian and American.
Dr. Alibek defected to the United States from the Soviet Union in 1992 and subsequently served as a consultant to numerous U.S. government agencies in the areas of industrial technology, medical microbiology, biological weapons defense, and biological weapons nonproliferation. He has worked with the National Institutes of Health, testified extensively before the U.S. Congress on nonproliferation of biological weapons and is the author of Biohazard, published by Random House. Now, he is finishing the second book Biohazard II: “The Anthrax Crisis”. |
| |
Academic Background:
Dr. Alibek holds an M.D. in epidemiology and infectious diseases, and additional degrees including a Ph.D. in medical microbiology and a D.Sc. In industrial biotechnology.
Dr. Ken Alibek is the Executive Director Education for George Mason University’s National Center for Biodefense and is a Distinguished Professor at George Mason University. He also holds the positions of President and Chief Scientist of Advanced Biosystems. As a Distinguished Professor of Medical Microbiology and Immunology, Dr. Alibek conducts research and teaches in the areas of microbiology, immunology, and biotechnology. |
| |
Research Interests:
Dr Alibek has given more than 300 lectures, seminars and presentations in the areas of biological weapons threat and defense, microbiology, and immunology for various military and civilian colleges and universities (including Princeton, Harvard, MIT, Brown, Dartmouth, Georgetown, Rockefeller, Univ. of Pennsylvania, Univ. of Virginia, National Defense University, Uniform Services University, Air Force, Naval, and Army Academies). Lectures and presentations given to the governments and academia of Great Britain, Sweden, France, Japan, Singapore, Netherlands, Germany, Switzerland, and Australia. |
|
| |
Recent
Publications |
| |
|
Effective antiprotease-antibiotic treatment of experimental anthrax |
|
S Popov T Popova S Hopkins R S Weinstein R MacAfee K J Fryxell V Chandhoke C Bailey K Alibek |
BMC Infectious Diseases 2005 5 25
|
|
|
Systemic Cytokine Response in Murine Anthrax |
|
S Popov T Popova E Grene F Klotz C Bailey J Cardwell C Bradburne Y Yama M Maland J Wells T Voss C BaileyA Nalca K Alibek |
Cell Microbiology 2004 6 225
|
|
|
Anaerobic Regulation of B. anthracis Hemolytic Activity |
|
V Klichko S Popov J Miller A Wu K Alibek |
Biochem. Biophys. Res. Commun. 2003 303 855
|
|
|
In vitro-generated respiratory mucosa: a new tool to study inhalational anthrax |
|
S Radyuk P Mericko T Popova E Grene K Alibek |
Biochem. Biophys Res Commun 2003 305 3 624
|
|
|
Anthrax lethal toxin inhibits the production of proinflammatory cytokines
|
|
A Wu J Shiloach L Li H Liu D Alibek C Bradburne J Kubler-Kielb J Moore J Cardwell C Lobanova K Alibek C Bailey |
submitted to European Journal of Immunology 2003
|
|
| |
| |
|
| |
|
|
|
|
|
